Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001543666 | SCV001762352 | uncertain significance | Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | 2021-07-27 | criteria provided, single submitter | clinical testing | CD46 c.72G>A (rs765047596) is rare (<0.1%) in a large population dataset (gnomAD: 1/251322 total alleles; 0.0004%; no homozygotes) and has not been reported in ClinVar nor the literature, to our knowledge. Three bioinformatic tools queried predict that this substitution would be tolerated and the methionine residue at this position is not evolutionarily conserved across the species assessed. We consider the clinical significance of CD46 c.72G>A to be uncertain at this time. |
Labcorp Genetics |
RCV003771668 | SCV004639257 | uncertain significance | not provided | 2023-03-08 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CD46-related conditions. This variant is present in population databases (rs765047596, gnomAD 0.002%). This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 24 of the CD46 protein (p.Met24Ile). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1185016). |